On November 29, 2021, the Board held a meeting via video conference with members of senior management of the Company and representatives from K&E and China Renaissance. Each of Ms. Lihong Wang, Mr. Jonathan Jia Zhu and Mr. Zhongjue Chen disclosed their respective interests in connection with the transactions contemplated by the Transaction Documents, including the Sale, at such meeting. Representatives of K&E then reviewed with the Board the key terms of the Transaction Documents. During the meeting, representatives of China Renaissance (i) reported to the Board that for the period from October 22, 2021 to November 29, 2021, China Renaissance reached out to a selected group of potential buyers as part of the market check process and there was no potential buyer interested in providing financing to or engaging in a corporate transaction with the Company, and (ii) made a presentation on its valuation analyses of the Company and evaluation of the Proposal from the financial and business perspective. After consideration and discussion of the proposed terms of the Transaction Documents, and the presentations of China Renaissance, the Audit Committee unanimously determined that the Transaction Documents and the transactions contemplated by the Transaction Documents, including the Sale, on the terms and subject to the conditions set forth in the Transaction Documents, are fair to, and in the best interests of, the Company and its shareholders, and declared it advisable for the Company to enter into the Transaction Documents and the transactions contemplated by the Transaction Documents, including the Sale. After the determination of the Audit Committee, the Board, with the applicable conflicted directors recusing, (i) determined that the Transaction Documents and the transactions contemplated by the Transaction Documents, including the Sale, on the terms and subject to the conditions set forth in the Transaction Documents, are fair to, and in the best interests of, the Company and its shareholders, (ii) authorized and approved the execution, delivery and performance of the Transaction Documents and the consummation of the transactions contemplated by the Transaction Documents, including the Sale, and (iii) resolved to direct that the Purchase Agreements and the transactions contemplated by the Purchase Agreements, including the Sale, be submitted to the shareholders of the Company for authorization and approval, with the recommendation of the Board that the shareholders of the Company authorize and approve the Purchase Agreements and the transactions contemplated by the Purchase Agreements, including the Sale.
Between November 29, 2021 and December 1, 2021, K&E, Haiwen, KWM, Latham and the Lenders’ counsel finalized the Transaction Documents.
On December 1, 2021, the Company, the Borrower, Rise HK, Rise IP, WFOE, VIE, the Buyer SPV, the Shareholder and the Lenders, as applicable, executed the Settlement Agreement, the WFOE Purchase Agreement, the IP Holdco Purchase Agreement, the Convertible Loan Deed, the Voting Undertaking and the other Transaction Documents.
When the Sale is Expected to be Completed
If the Sale Proposal is approved by our shareholders at the extraordinary general meeting, we expect to complete the Sale as soon as practicable after all of the other closing conditions in the Purchase Agreements have been satisfied or waived. We, the Shareholder and the Buyer SPV are working toward satisfying the conditions to closing and completing the Sale as soon as reasonably practicable. Subject to the foregoing, we currently anticipate to complete the Sale in December 2021. However, there can be no assurance that the Sale will be completed at all or, if completed, when it will be completed.
Recommendation of Our Board of Directors
After careful consideration by the Board of Directors, the Board (with the applicable conflicted directors recusing) unanimously approved the Purchase Agreements, the Sale and the other transactions contemplated thereby, and unanimously determined that the Sale and the terms of the Purchase Agreements are advisable to, and in the best interests of, the Company and its shareholders.
Accordingly, the Board (with the applicable conflicted directors recusing) unanimously recommends that shareholders vote “FOR” approval of the Sale Proposal and “FOR” approval of the Proposal to Adjourn the Extraordinary General Meeting.
38